Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03906708 · ClinicalTrials.gov registry record

Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature

A clinical trial of Premature Lungs, sponsored by Indiana University.

Active
Registry status
249
Enrollment target
1
Study location

NCT03906708 is a study of Premature Lungs that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 249 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03906708, a study of Premature Lungs, is active but no longer recruiting, sponsored by Indiana University.

ACTIVE NOT RECRUITING
Registry status
249 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.

Conditions Studied

Interventions

  • OTHER Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)

Study Locations (1)

Indiana

  • Jeff Bjerregaard - Indianapolis

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2019-01-01
Est. Completion 2026-12

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03906708

The ClinicalTrials.gov registry entry for NCT03906708 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Premature Lungs appearing as the primary indexed condition, and to 1 intervention - of which Diffusion Capacity of the Lung for Carbon Monoxide (DLCO) is the first listed.

NCT03906708 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03906708 about?

NCT03906708 is a clinical study titled "Physiological Phenotyping of Respiratory Outcomes in Infants Born Premature". The purpose of this study is to examine if infants are more likely to suffer from respiratory complications during their first year of life due to being born premature.

What is the current status of trial NCT03906708?

This trial is currently active not recruiting. The enrollment target is 249 participants. The study started on 2019-01-01. Estimated completion is 2026-12.

What conditions does trial NCT03906708 study?

This clinical trial studies the following conditions: Premature Lungs.

What interventions are being tested in trial NCT03906708?

The interventions under investigation include: Diffusion Capacity of the Lung for Carbon Monoxide (DLCO) (OTHER).

Who is sponsoring clinical trial NCT03906708?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03906708 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Lungs

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.